American Association for Clinical Chemistry
Better health through laboratory medicine
July 2007 Clinical Laboratory News: New Product Review

   
July 2007: Volume 33, Number 7


Oral Fluid Collection Media

Filtrona Fibertec® Trasorb® SCM (Saliva Collection Media) is ideal for obtaining oral fluid diagnostic samples.  Drawing on a broad range of fiber types, Filtrona Fibertec customizes Transorb SCM for optimum saliva absorption and recovery of targeted analytes. Media components are self contained and structurally sound, with no fraying or shedding. Filtrona Fibertec components can be made nonabrasive and of proper texture to ensure comfort and prevent the introduction of blood contaminants to the sample. Filtrona Fibertec Transorb SCM is especially well suited for drugs-of-abuse applications. Transorb SCM has been precisely engineered to maximize THC recovery, with independent data suggesting recovery rates over 98% at 5ng/mL concentrations.

 

Customized Rapid Diagnostics Media

Filtrona Fibertec® Transorb® Rapid Diagnostics Media is ideal for use as precise wicking materials, absorbent pads, and in some applications, conjugate pads, for lateral- flow assay applications. The media may be engineered to select capillarity and sample volumes and resistant to non-specific binding.  Its high tensile strength delivers optimum processing mechanics in roll stock form.  Filtrona Fibertec media will not crimp or tear as cellulose-based products.  In-house fiber processing and development enables lot-to-lot consistency and within-lot uniformity. Filtrona Fibertec manufactures bonded fiber components used to collect, wick, manipulate, control or filter diagnostic samples and other fluids on the microliter and milliliter scale.

 

2nd Generation Direct Hemoglobin A1c Reagent

This 2nd generation reagent for the determination of HbA1c on chemistry analyzers has improved stability of the sensitivity of the combined R2 reagents. As a result, in many settings, calibration stability and combined R2 reagent stability will be improved. The percentage of HbA1c is determined directly using on-board lyse applications on many chemistry systems. The method is based on competitive binding, latex-enhanced immunoturbidimetric analysis. The reagents are liquid stable and easily adapted to analyzers capable of handling two reagents. The four-level calibrator set is NGSP certified with values provided in percentage of HbA1c. A two-level control set is also available.


Urine Collection System

Introducing the Void Ease Bag for the collection of urine for urine tests. The bag makes urine collection easier, especially for women and children compared to the traditional cup, and the contents will not leak due to the patented, one-way valve. The urine sample can be extracted directly from the collection bag to the attached test tube for distribution to the testing laboratory. In addition, the specimen tube can be refrigerated to avoid corrupting the urine sample. With its sealed design of collection, extraction, and containment system, the Void Ease Bag also prevents contamination of lab professionals. In addition, urine spills are avoided because transferring the urine to a test tube is avoided.


Jaguar Analyzer

The Jaguar analyzer will automatically perform all aspects of nucleic acid testing, including sample preparation, amplification, and detection for up to 48 samples per hour with the first 24 results available in less than an hour. The Jaguar system will enable customers to overcome the three main disadvantages of NAT: time, complexity and cost. Contamination and carryover risks, which are high in current NAT environments that are dependent upon manual sample preparation and processing steps or “open tube” PCR, drop to nearly zero. Training requirements are expected to change from long and complicated to brief and simple, plus the Jaguar instrument's performance is expected to meet or exceed current NAT systems and culture. Jaguar offers a radical, yet logical and straightforward, advancement in nucleic acid testing.


Hemosure® One-Step Immunological FOBT

The one-step, easy to use Hemosure immunological FOBT is the latest technological breakthrough in immunological fecal occult blood testing (IFOBT). FDA approved and CLIA waived, the Hemosure immunoassay employs a unique combination of monoclonal and polyclonal antibodies to detect only human blood in stool. As a result, abstinence of food and drugs before taking the test is no longer necessary, advantages that can significantly enhance patient compliances.


Systec® Transfer-Line Debubbler

Introducing the Systec Transfer-Line Debubbler for diagnostic and life science instruments. This new debubbler for low pressure systems improves on passive bubble-trap technology with active bubble removal and transfer-line degassing. Available in three sizes scaled to commonly dispensed volumes, the debubbler helps equipment manufacturers improve dispensing precision, reduce sample loss and reagent usage, and improve analytical accuracy in high-throughput diagnostic applications. The new Systec debubbler features an inert, tubular, semi-permeable degassing membrane that extends into the transfer line to remove gasses from dispensed liquids. Bubbles created after degassing, such as by cavitation, are trapped and extracted by vacuum.

 

Sapphire Engineering® VFP-17 Precision Dispense Pump

Presenting the new Sapphire Engineering VFP17 precision dispense pump. Designed with long-life Zirconia ceramic displacement piston technology, the VFP17 precision dispense pump offers high precision and low cost of ownership at a value price to meet the cost constraints of lab automation and diagnostic applications. Features include: guaranteed pump life of millions of cycles; available total dispense volumes of 25 µL to 5 mL; optional seal wash for difficult fluids; dispense volume accuracy of less than 1%CV; and a flexible pump head design allowing easy integration with valves, manifolds, and other components.

QUANTA Lite™ CCP3.1 Assay

The QUANTA Lite CCP3.1 IgG/IgA (cyclic citrullinated peptide) ELISA is an improved version of CCP3, the third-generation assay, featuring a blended, dual-specificity IgG/IgA conjugate. The exact sequence of CCP3.1 is proprietary and patent pending. Antibodies from patients with rheumatoid arthritis (RA) react very specifically with CCP on the solid phase. The use of a blended anti-IgG and IgA affinity-purified conjugate allows the detection of antibodies in a small but significant cohort of RA patients that do not react with IgG alone. The QUANTA Lite CCP3.1 ELISA offers up to a 9% increase in sensitivity for the detection of early RA patients over that seen with CCP2. In addition, the specificity of CCP3.1 is increased over that observed in earlier CCP2 assays.
 

QUANTA Lite™ Celiac DGP Kits

The QUANTA Lite Celiac DGP (deamidated gliadin peptide) IgG, IgA, and screening kits feature a novel, entirely synthetic peptide. While the exact sequence is proprietary and patent pending, the molecule contains fewer than 35 amino acids. This peptide is derived from whole molecule gliadin and has been selectively deamidated, causing glutamine to convert to glutamic acid, thus mimicking the action of tissue transglutaminase (tTG). The peptide incorporates the major B cell epitopes in a conformationally intact manner. These kits offer greater than 97% agreement with tTG and endomysial results, vastly enhanced specificity with a less than 1% false-positive rate, and increased sensitivity for the detection of celiac disease.


AIMS—Automated Immunoassay Multiplexing System

The AIMS (Automated Immunoassay Multiplexing System) is a fully automated platform that allows the processing of AtheNA Multi-Lyte® assays and Wampole ELISA II® assays. The system is the first fully integrated and open system that allows the processing of microplate-based assays utilizing the proprietary Luminex x-MAP® technology, as well as traditional ELISA-based assays. The AIMS system allows laboratories to maximize their efficiency by offering complete walk-away performance. The AIMS system is the latest addition to the AtheNA Multi-Lyte product line, which offers the largest FDA-cleared, multiplexing menu.


OneTouch® DataLink® Wireless

This product brings a new level of freedom to the point-of-care environment. Now, healthcare providers can enjoy flexible, secure wireless connectivity between OneTouch Flexx™ Meters and the OneTouch DataLink Data Management System. The OneTouch DataLink Wireless system improves workflow and data transfer processes with meter data reportable in near real time for enhanced clinical decisions. The OneTouch DataLink Wireless system is part of our commitment to Integrated IntelligenceSM solutions, providing healthcare institutions with the tools and technology they need to advance care across the continuum.

 

IRMA TRUpoint® System

Announcing a new assay on the IRMA Trupoint System to measure lactate concentration in blood at the patient bedside. Measuring lactate can provide important diagnostic information for the care of patients and help avoid serious complications that could increase patient morbidity and mortality. Another IRMA TRUpoint system development includes the release of new software that calculates the modification of diet in renal disease glomerular filtration rate (MDRD GFR) with every creatinine test result. Higher than normal serum creatinine levels can indicate renal failure. The new software program takes the IRMA creatinine result and applies the NKDEP formula factoring the patient's age, race and sex to assess overall kidney function. These recent additions further enhance the IRMA TRUpoint system's value for rapid, accurate point-of-care testing in emergency and critical care situations where immediate results can make a difference in treatment decisions.

 

AVOXimeter Systems

The AVOXimeter1000E and 4000 systems are portable, easy to use analyzers that provide rapid, accurate assessment of a patient's true oxygenation status at the bedside. Testing is performed in single use disposable cuvettes. No sample preparation is required—simply inject whole blood sample into the cuvette, and insert into the analyzer. Results are displayed and recorded in less than 10 seconds, improving efficiencies and allowing for timely diagnosis and intervention. The AVOXimeter4000 analyzer measures oxyhemoglobin, carboxyhemoglobin, methemoglobin, total hemoglobin, and oxygen content and is used in the respiratory department, ICU, OR, NICU, and the ED. The AVOXimeter1000E analyzer is specifically designed for the cardiac cath lab and measures oxygen saturation, oxygen content, and total hemoglobin concentration.


APN Series Diaphragm Air Pump

The APN Series diaphragm air pump is highly suited for system integration. Combining a high-performance motor with a specially designed diaphragm and a reinforced connecting rod increases vacuum efficiency, start-up capabilities, and durability. Additionally, utilizing specially-designed bearings that reduce wear increases the pump service life. Its many medical applications include aspirators, nebulizers, low-frequency pulse treatment machines, sphygmomanometers, biochemical analyzers, endoscope X-ray gas sterilizers with film suction and feed, milking machines, artificial respirators, and interferometric treatment machines.


IgGs and Secondary Antibodies

Announcing an expanded line of purified IgGs and secondary antibodies for use in immunoassays. A wide selection of species and purity levels are available to facilitate assay optimization, and lot sizes are sufficient to allow qualification of a single lot to support both assay development and subsequent production. Free technical support is available as well.  Production facilities are compliant with EC No.1774/2002 regulations to enable shipment of materials to European Union member countries.


OneTouch® DataLink® Web

Single-point control and flexibility are the hallmarks of the OneTouch DataLink Web system. Built on thin client-server technology and Microsoft Windows Server 2003 functionality, the new Web system offers optimized system performance. The One-Touch DataLink Web system makes it easier to access, manage, and share data, which can enhance clinical decision making. Healthcare providers can access patient information anytime and anywhere, from the Internet or their Intranet. It's one of several connectivity options we offer, all in the interest of bringing Integrated IntelligenceSM solutions to the point-of-care environment to help our partner institutions achieve better clinical and financial outcomes.

 

OneTouch® TGC™ Advisor

As more healthcare institutions adopt tight glycemic control protocols, the need for tools to optimize these protocols becomes clear. Announcing a new tool that makes it easier to measure and manage the information necessary for tight glycemic control implementation: the OneTouch TGC Advisor system. Part of the OneTouch DataLink® Data Management System, it is configurable by location and reportable by patient. It generates real-time patient graphs and trend reports that can easily be distributed via e-mail. Like our other products and technologies, the OneTouch TGC Advisor system offers Integrated IntelligenceSM solutions for improved clinical and financial outcomes.


xPONENT™ Software

xPONENT software combines ease of use and flexibility to perform both protein and nucleic acid testing on one system. xPONENT software was developed with experts in human factors and ergonomic design. Customer-centric development and extensive field testing has resulted in a user experience that is a significant step forward in the marketplace. The software suite incorporates over 300 new features, all designed to simplify laboratory workflow and increase productivity. New features include enhanced security (21 CFR Part 11 compliance and electronic signatures), integration capabilities that allow users to transmit and receive data from LIS/LIMS, integration with the most popular automated sample preparation systems, the ability to run magnetic bead applications, and touch-screen capability.

 

MagPlex™ Microspheres

MagPlex microspheres feature superparamagnetic properties that make them ideal for running automated xMAP-based assays. These microspheres can be moved or held in place by a magnetic field. Many automated sample preparation systems use magnetic properties to automate the sample preparation steps in an assay. Automating sample testing using MagPlex microspheres on a robotic sample preparation system will minimize hands-on technician time, improve precision, and streamline workflow.

 

ID-Tag™ RVP*

The ID-Tag RVP (respiratory viral panel) is a comprehensive assay for the detection of up to 20 viral strains and subtypes, including H5 (avian influenza). The assay was designed to allow better decisionmaking in patient management and to limit the spread of infection. The assay tests for up to 20 different viruses and subtypes important for surveillance and patient management and eliminates guesswork. The assay was designed not only to detect the infecting virus or viruses but also to provide reliable information on which viruses are not present. Providing results in a single shift and fast enough to be used clinically, the ID-Tag RVP is cost-effective, too, with one low price for information on all viral targets. *For investigational use only.

 

FlexmiR™ microRNA Profiling System

The FlexmiR microRNA profiling system combines bead-based xMAP® multiplex technology with Locked Nucleic Acid (LNA™)-modified capture probes. The system performs in-solution expression analysis of microRNA sequences from the miRBase database using total RNA samples without the need for amplification. The simple, 4-hour protocol allows researchers to biotinylate the 3´-ends of total RNA, followed by a hybridization step where the labeled microRNA hybridizes specifically to LNA capture probes coupled to xMAP microspheres. The detection of the biotinylated microRNA is achieved by the reaction with streptavidin-phycoerythrin, with final read of the samples in a standard 96-well plate on an analyzer.


Horizon Anatomic Pathology™ System

The Horizon Anatomic Pathology system is a new, next-generation anatomic pathology application that meets the needs of pathologists in an increasingly demanding and competitive environment by improving both workflow and diagnostic processes. The system features advanced technologies, such as an intelligent, customizable, workflow management system and the Virtual Slide Tray™, a case-centric, ‘home base' for the pathologist to receive and perform work from a single screen, including correlations, stain and recut orders, and consults. The Horizon Anatomic Pathology system also features clinical pathology data and PACS integration. The system is integrated with the Horizon Lab™ laboratory information system.


EasyRA Clinical Chemistry Analyzer

Introducing the EasyRA instrument, a fully automated, random access clinical chemistry analyzer that accommodates the diverse needs of the physician's office or small laboratory. EasyRA analyzers offer the reliability of larger instruments, all within an easy-to-use, economical, bench-top design. An easy-to-learn interface leads users through analyzer operation using a friendly and intuitive layout. Maintenance is simplified, with all components that require periodic replacement conveniently accessible in a unique slide-out drawer. With 150 tests per hour (>300 with integrated ISE), 24 sample positions, 24 reagents on-board, and much more, you will understand why EasyRA will be an easy choice for your lab.


Actim™ PROM Rapid Test

The actim PROM rapid test for the detection of premature rupture of fetal membranes (PROM) has received clearance from the FDA for the U.S. market. Actim PROM has been developed to improve the diagnosis of PROM. On the market outside the U.S. since 1995, it was the first test that recognizes a protein highly specific for amniotic fluid. This makes it less susceptible to interfering factors that cause possible false-positive or false-negative results by other test methods. This superior reliability has made the actim PROM test the method of choice in several countries.


ND-8000 8-Sample Spectrophotometer

The ND-8000 8-Sample Spectrophotometer provides higher-throughput analysis of 1-µL samples. The ND-8000 system takes full-spectrum UV/Vis absorbance measurements of eight samples simultaneously, allowing researchers to work with larger numbers of samples in less time, while providing the overall capabilities and ease-of-use of the popular ND-1000 spectrophotometer. An eight-channel pipette is used to quickly dispense the samples onto a linear array of eight pedestals. This enables 96 samples to be measured within 10 minutes. Researchers can now perform quality control checks at critical points throughout workflows in ways that are either difficult or not feasible using single-sample spectrophotometers or plate readers.


AU3000i™ Immunoassay System

The AU3000i immunoassay system is designed with the same focus on quality, reliability, and efficiency that distinguish the brand of clinical chemistry and blood banking systems worldwide. Features include random-access processing and STAT-interrupt flexibility, magnetic-particle capture and chemiluminescent detection for excellent sensitivity and linearity, and up to 240 tests per hour throughput. Standardized operating software with AU clinical chemistry systems, a touch-screen interface, onboard videos, and an integrated user's guide provide ease of use. In addition, the SUPPORTVISION™ system, an internet-based device management system for these analyzers, allows real-time monitoring of instrument performance and proactive service intervention for enhanced customer support.

 

Partner Advantage™ Programs

The Cyto-Chex Blood Collection Tube (BCT) is a vacuum-draw tube intended for whole-blood sample collection, preservation, and transport. The Cyto-Chex BCT is designed to preserve cellular morphology and cell-surface epitopes allowing for the characterization and enumeration of unique cell types, including rare or fragile cells. Recent studies demonstrate that tumor-specific antigens are preserved for up to 5 days in the Cyto-Chex BCT, but show degradation at 24 hours in a standard EDTA tube. The Cyto-Chex 10-mL BCT is the only product available for preservation of direct blood draws without significant dilution of the sample.


VITROS® Anti-HAV IgM Assay

The VITROS® Anti-HAV IgM Assay is now available in the U.S. and international markets on the VITROS® ECi/ECiQ Immunodiagnostic System using Intellicheck® Technology. This assay tests individuals who have signs and symptoms consistent with acute hepatitis. Assay results, in conjunction with other clinical information, may be used for the laboratory diagnosis of individuals with acute or recent hepatitis A. The VITROS hepatitis offering is now complete for the routine markers for hepatitis A, B, and C, enabling laboratories to easily perform these assays in full, random-access 24/7, while consolidating testing to control costs, improving operational efficiency, and optimizing labor.

 

VITROS® Total ß-hCG II Assay

Announcing the availability the new VITROS Immunodiagnostic Products Total ß-hCG II assay for use with the VITROS® ECi/ECiQ Immunodiagnostic System using Intellicheck® Technology. This assay is intended for the quantitative measurement of human chorionic gonadotropin (hCG) and its ß-subunit in human serum and plasma (heparin and EDTA) to aid in the early detection of pregnancy. The new VITROS Total ß-hCG II assay provides enhanced testing capabilities with an extended measuring range up to 15,000 mIU/mL, excellent sensitivity and precision, and no high-dose hook effect up to 1,300,000 mIU/mL.

 

VITROS® Troponin I ES Assay

Announcing the availability of VITROS Troponin I ES assay with improved low-end sensitivity. The assay is for use with the VITROS ECi/ECiQ Immnuodiagnostic System using Intellicheck® Technology. The VITROS Troponin I ES assay is used for the quantitative measurement of cardiac troponin I in human serum and plasma to aid in the assessment of myocardial damage and risk stratification. The VITROS Troponin I ES assay is compliant with the recommendations as described by the Joint European Society of Cardiology/American College of Cardiology Committee (ESC/ACC) for acceptable imprecision in a high-sensitivity troponin I assay.

 

VITROS® Rubella IgG Assay

The VITROS® Rubella IgG Assay is now available in the U.S. and international markets as an aid in the determination of immunity to rubella infection, commonly known as German measles. The presence of rubella IgG antibodies may indicate a recent or past rubella infection or that a rubella vaccine has been given and is providing adequate protection. The assay is performed in full, random access with more than 40 tests worldwide for thyroid function, reproductive health and fertility, bone metabolism, anemia, metabolic, oncology, emergency cardiology, and infectious diseases on the VITROS ECi/ECiQ Immunodiagnostic System using Intellicheck® Technology.

 

VITROS® Homocysteine Assay

Announcing the availability of a new MicroTip™ assay to measure homocysteine concentration in serum and plasma on the VITROS 5,1 FS Chemistry System. Unlike many competitive assays, the VITROS homocysteine assay is differentiated by calibration stability up to lot change and no reagent preparation. In addition, the VITROS 5,1 FS Chemistry System provides freedom from carryover issues due to the utilization of single-use tips for both sample and reagent handling, thus preventing erroneous results and reagent cross-contamination with other assays. Finally, the VITROS homocysteine assay demonstrates excellent correlation to HPLC.

 

VITROS® Anti-HAV Total Assay

The VITROS Anti-HAV Total Assay is now available in the U.S. and international markets on the VITROS® ECi/ECiQ Immunodiagnostic System using Intellicheck® Technology. This test, together with other serological and clinical information, is used to help determine whether a patient has a previous, ongoing infection from hepatitis A virus (HAV) or is susceptible to the virus. The VITROS hepatitis offering is now complete for the routine markers for hepatitis A, B, and C, enabling laboratories to easily perform these assays in full random-access 24/7 while consolidating testing to control costs, improving operational efficiency, and optimizing labor.

 

VITROS® Drugs-of-Abuse Assays

Announcing the availability of a drugs-of-abuse (DAT) family of MicroTip™ assays for use on the VITROS® 5,1 FS Chemistry System. VITROS DAT assays include amphetamines, barbiturates, benzodiazepines, cocaine metabolites, methadone, opiates, phencyclidine, and THC. Unlike some competitive assays, all of the VITROS DAT assays are differentiated by calibration stability up to lot change, plus both qualitative and semi-quantitative reporting options. Finally, freedom from carryover is provided by the utilization of single-use tips for both sample and reagent handling on the VITROS 5,1 FS Chemistry System, preventing erroneous results.


eSensor® XT-8 System*

Introducing the eSensor XT-8 System for 2C9/VKOR testing. This next generation eSensor platform allows users to perform testing for CYP450 2C9 and VKORC1 polymorphisms in either a random-access or batch-mode setting. User interaction is effortless with the on-board, touch-screen interface. The eSensor 2C9/VKOR kit contains all reagents necessary for PCR amplification and polymorphism detection in a single box. Easy-to-interpret reports provide genotype information for individual polymorphisms included in the panel, as well as information regarding warfarin sensitivity. Pending FDA clearance.


CO2 Liquid-Stable Reagent with NADH-Analog Technology

Based on PEPC/MDH enzymatic analysis, this reagent for the determination of CO2 is liquid stable with a shelf life of 15 months. The indicator reaction incorporates an NADH analog that is reduced to yield a decrease in absorbance which is proportional to the concentration of CO2 in the sample. The use of the NADH analog provides a reagent that has excellent on-board stability and calibration stability. The liquid-stable CO2 reagent has an assay range of 1–40 mmol/L and has been adapted to many clinical chemistry analyzers. Calibrators and controls for the assay are also available.


 e.lixa™ Suite

 The e.lixa suite of LIS extension applications represents a new class of laboratory software designed to add new functionality to a laboratory's existing LIS easily and affordably. Laboratories can select one or all of the e.lixa modules based on its particular needs—to handle new types of molecular or genetic testing, enhance the marketability of its services, to retain or gain new clients, or to more easily address compliance. The e.lixa suite gives laboratories the tools they need to meet new business demands without the cost and complexity of an upgrade or new LIS. It also serves as an off-site data back-up.


Workstation™ Sorter / Aliquoter

The Workstation™ system combines an aliquoting and a sorting system with a single-, double-, or triple-centrifuge module. It automates all important front-end and back-end features: centrifuging; tube type identification via cap recognition; sample quality control; selective decapping; barcode printing and labeling; aliquoting; sorting; recapping; and archiving. With a throughput of up to 1,200 tubes per hour and the use of all kinds of standard racks, tubes, and generic consumables, the Workstation system is a fast, flexible, and cost-efficient solution.

 

High Throughput Sorter ProV™—Series 2007

The High Throughput Sorter ProV is a compact front-end and back-end solution for medium- and high-volume laboratories. The system, which sorts and selectively decaps tubes, is fast and also accepts a variety of tubes and racks. An optional recapping module and a tube type identification system using cap recognition can be integrated. Secure and tight low-cost foils are used for archiving. The ProV instrument can be used as a stand-alone system or can be connected to a single- or double-centrifuge module.


Cardiasure™ Cardiac Markers Controls

Cardiasure Cardiac Markers controls are intended as a means of monitoring serum cardiac analyte testing methods. A new feature is the addition of NT-proBNP. The markers are compatible with most major chemistry analyzers and have a liquid, human serum matrix. The product comes with full 3 year frozen stability from date of manufacture and can be refrozen twice. It is available at three levels that have 90-day, unopened and 60-day, open-vial stability when stored at 2–8°C. The controls are packaged in a dropper tip plastic bottle for ease of use. A comparative quality control program, Quantrol™, is also available.


QuickVue® RSV Test

The QuickVue RSV test is a dipstick immunoassay that allows for the rapid, qualitative detection of respiratory syncytial virus (RSV) antigen directly from nasopharyngeal swab, nasal /  nasopharyngeal  wash, or nasopharyngeal aspirate specimens for symptomatic pediatric patients. The test is intended for use as an aid in the diagnosis of acute respiratory syncytial viral infections.

 

QuickVue® iFOB Test

The QuickVue iFOB test is a CLIA-waived, rapid immunochemical diagnostic tool intended to detect the presence of human blood in stool specimens. Blood in the stool is an indication of a number of gastrointestinal disorders, including colorectal cancer. The new 50 Test Tray Pack is designed to meet the specific needs of acute-care customers and large-volume accounts. Bedside collection tubes are packaged in trays of 10, allowing for distribution throughout the facility. Rapid-test cassettes are housed in the central laboratory, providing results within 10 minutes.